Fundz Deep Dive
Everything you need to win Nucleus RadioPharma — in one platform.
Who to reach, what to say, and why now on Nucleus RadioPharma — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Nucleus RadioPharma — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Nucleus Radio Pharma Appoints Tyrell Rivers As Executive Director of Corporate Ventures
PRIVATEJun 05, 2024•about 2 years ago
Company
Nucleus RadioPharma
DavidsonManufacturingBiotechnologyHealth CarepharmaceuticalsDescription
Nucleus RadioPharma has announced the closing of a Series A extension round with new investor AstraZeneca. Concurrent with the financing, Tyrell Rivers was appointed as the Executive Director of Corporate Ventures at AstraZeneca.
Related People
Suggested for you
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months